Search
01/03/2025
Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.
Santos García D, Pagonabarraga Mora J, Escamilla Sevilla F, García Ruiz PJ, Infante Ceberio J, Kulisevsky Bojarski J, Linazasoro Cristóbal G, Luquín Piudo MR, Martínez Castrillo JC, Jesús Maestre S, Vela Desojo L, Campos Lucas FJ, Caballero Martínez F, Mir P. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.. Neurologia. 2025; 40(2)DOI:10.1016/j.nrleng.2023.04.008. PMID:37419211. IF:(Q/D).
01/03/2025
Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results
Sumarroca, A, Vega, C, López, S, Leidinger, A, Pedemonte, G, León, X, Costa-González, JM. Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results. Acta Otorrinolaringologica Espanola. 2025; 76(2)DOI:10.1016/j.otorri.2024.10.001. PMID:39923991. IF:(Q/D).
01/03/2025
Depressive Symptoms and Amyloid Pathology
Wiels, WA, Oomens, JE, Engelborghs, S, Baeken, C, von Arnim, CAF, Boada, M, Didic, M, Dubois, B, Fladby, T, van der Flier, WM, Frisoni, GB, Froehlich, L, Gill, KD, Grimmer, T, Hildebrandt, H, Hort, J, Itoh, Y, Iwatsubo, T, Klimkowicz-Mrowiec, A, Lee, DY, Lleo, A, Martinez-Lage, P, de Mendonca, A, Meyer, PT, Kapaki, EN, Parchi, P, Pardini, M, Parnetti, L, Popp, J, Rami, L, Reiman, EM, Rinne, JO, Rodrigue, KM, Sanchez-Juan, P, Santana, I, Sarazin, M, Scarmeas, N, Skoog, I, Snyder, PJ, Sperling, RA, Villeneuve, S, Wallin, A, Wiltfang, J, Zetterberg, H, Ossenkoppele, R, Verhey, FRJ, Vos, SJB, Visser, PJ, Jansen, WJ. Depressive Symptoms and Amyloid Pathology. JAMA Psychiatry. 2025; 82(3)DOI:10.1001/jamapsychiatry.2024.4305. PMID:39841452. IF:17.100(Q1/1D).
01/03/2025
Poliquistosis renal autosómica dominante: riesgo de progresión y perspectivas de tratamiento en edad pediátrica
Fraga Rodríguez GM, Devolder Nicolau, A. Poliquistosis renal autosómica dominante: riesgo de progresión y perspectivas de tratamiento en edad pediátrica. Anales de Nefrología Pediátrica. 2025; 1(10)DOI:. PMID:. IF:(Q/D).
01/03/2025
Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care: A Mixed-Method Evaluation Study.
Majoie M, Visser A, Ulubas M, van Mastrigt G, Alonso-Coello P, Valli C, Niño de Guzman E, Gartlehner G, Nussbaumer-Streit B, Klerings I, James R, Service D, Evers S, Kleijnen J, Leone M, Verstegen D. Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care: A Mixed-Method Evaluation Study.. Neurology. Education. 2025; 4(1)DOI:10.1212/NE9.0000000000200198. PMID:40041757. IF:(Q/D).
01/03/2025
Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus
Villaverde, S, Pedrero-Tomé, R, Papaevangelou, V, Syridou, G, Karagiannidou, S, Lyall, H, Payne, H, Frick, MA, Soler-Palacín, P, Baquero-Artigao, F, Rodríguez-Molino, P, Fortuny-Guasch, C, Rios-Barnés, M, Sánchez-Mateos, M, Saavedra-Lozano, J, Bringué, X, Moliner, E, Castells, L, Muga, O, Vives-Oños, I, Gkentzi, D, Lombardi, G, Tagarro, A, Colino, E, Couceiro, JA, Rojo, P, de Vergas, J, Blázquez-Gamero, D. Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2025; 44(3)DOI:10.1097/INF.0000000000004583. PMID:39383383. IF:2.200(Q2/3D).